Basic Information
| LncRNA/CircRNA Name | SLC25A5-AS1 |
| Synonyms | NA |
| Region | GRCh38_X:119466034-119469098 |
| Ensemble | ENSG00000224281 |
| Refseq | NR_028443 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR |
| Sample | GC tissue |
| Expression Pattern | down-regulated |
| Function Description | The results showed that the expressions of SLC25A5-AS1 in GC were significantly lower than that of adjacent normal tissues, which were significantly associated with tumour size, TNM stage and lymph node metastasis. |
| Pubmed ID | 30793479 |
| Year | 2019 |
| Title | Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer. |
External Links
| Links for SLC25A5-AS1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |